Blood Clot Problems from Xeljanz Draw Updated EMA Warning for High Risk Patients
European regulators warn that Xeljanz should not be given to any patients at high risk of blood clots unless absolutely necessary.…
«
»
European regulators warn that Xeljanz should not be given to any patients at high risk of blood clots unless absolutely necessary.…
Side effects of the rheumatoid arthritis and ulcerative colitis drug Xeljanz may result in the development of serious and potentially lethal pulmonary embolism. Lawsuits are being reviewed by lawyers nationwide.…
The FDA is warning that Pfizer’s ulcerative colitis drug, Xeljanz, could cause pulmonary embolism and deep vein thrombosis at higher doses.…
European regulators have placed new restrictions on the use of Xeljanz while they continue to review potential pulmonary embolism risks.…
Xeljanz side effects may increase the risk of pulmonary embolism by a factor of five when taken at higher doses, according to the preliminary findings of a clinical trial.…
Pfizer is suing Ajanta Pharma over plans to release a generic version of Xeljanz years before its patent protection is scheduled to run out.…
A new study links the use of birth control and hormone replacement therapy to different aspects of inflammatory bowel disease.…
The findings of a new study indicate that some food additives may disrupt gut bacteria, leading to metabolic syndromes.…
A New Jersey appeals court has overturned a $2.1 million Accutane verdict own by a California woman in 2010.…
A New Jersey jury has awarded $1.5 million to a woman who had her colon removed due to complications from ulcerative colitis, which she says was caused by Accutane…